Butirosin disulfate CAS:51022-98-1
Butirosin disulfate is commonly employed in veterinary medicine to combat bacterial infections in animals. It is particularly effective against gram-negative bacteria such as Escherichia coli, Salmonella spp., and Pseudomonas aeruginosa. Butirosin disulfate is administered orally or through injection to target systemic infections or topically to treat localized infections on the skin or mucous membranes. Veterinarians carefully assess the type of infection, its severity, and the animal's health condition when determining the appropriate dosage and administration route for butirosin disulfate. It is crucial to follow the prescribed treatment regimen accurately and complete the full course of antibiotics to ensure the infection is adequately eradicated and prevent the development of antibiotic resistance. Monitoring for any signs of adverse reactions, such as allergic responses or kidney damage, is essential during treatment with butirosin disulfate. Veterinary professionals may conduct periodic tests to evaluate the animal's response to the antibiotic therapy and adjust the dosage if necessary. Proper storage and handling of butirosin disulfate are critical to maintaining its efficacy and safety for veterinary use, emphasizing the importance of compliance with veterinary instructions and guidelines.
Composition | C21H45N5O20S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 51022-98-1 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |